ALMB-0168 / CSPC Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ALMB-0168 / CSPC Pharma
ACTRN12620000440921: A Phase 1 Trial of ALMB-0168 in Patients with Malignant Bone Disease

Terminated
1
35
 
Avance Clinical Pty Ltd, AlaMab Therapeutics, Inc.
Osteosarcoma or any other solid tumor cancer with bone metastases
 
 

Download Options